[5-HT3 antagonists in therapy of cystostatic drug-induced vomiting].
Marschner
N
N
Medizinische Universitätsklinik Göttingen.
Beyer
J H
JH
Räth
U
U
Souchon
R
R
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017294:Ondansetron / Q000009:adverse effects / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000970:Antineoplastic Agents; D017294:Ondansetron
5-HT3-Antagonisten in der Therapie des zytostatika-induzierten Erbrechens.